Tyrosine kinase inhibitor-induced severe bullous pemphigoid in a patient with advanced stage of liver cancer: a case report and literature review
Yu Li,
Tingting Wang,
Mi Wang
Abstract:Apatinib, a novel vascular endothelial growth factor receptor-2 (VEGFR2)
targeted chemotherapy for solid tumors, has revealed promising efficacy
in treating liver cancer in China. Although it has been reported to have
a high incidence of inducing hand-foot skin reactions, other skin
adverse reactions induced by apatinib are rare. Herein, we report a rare
case of apatinib-induced severe bullous dermatosis that was successfully
treated with methylprednisolone and summarize the dermatologic
toxicities of VEGFR ty… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.